安吉戴纳米克斯 ANGO
$11.73 −$0.08 (-0.68%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $11.73 0.00%
开盘$11.62
昨收$11.81
当日区间$11.52 – $11.81
成交量363.7K
市值$493.30M
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例92.0%-1.15 个百分点，较上季度
持仓机构数198-2 ，较上季度
内部人近期交易32次买入 / 18次卖出净买入
空头持仓比例4.56% 占流通股回补天数 1.5 · 截至 15 Oct 2026
卖空成交量占比25.9%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：+$804.2K（12个净流入日，8个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有33.6%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从2.96%升至4.56%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Y-Intercept (Hong Kong) Limited | Mutual Fund | 2026/Q3 | +78,328 | 0.3% |
| Stephen Trowbridge | Individual/Insider | 2026/Q3 | +41,823 | 0.4% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +69,108 | 1.1% |
| James Clemmer | Individual/Insider | 2026/Q3 | +90,208 | 1.5% |
| Laura Piccinini | Individual/Insider | 2026/Q3 | +67,286 | 0.2% |
| Chad Campbell | Individual/Insider | 2026/Q3 | +63,873 | 0.2% |
| Stephen Trowbridge | Individual/Insider | 2026/Q3 | +36,561 | 0.4% |
| Royce & Associates, LP | Mutual Fund | 2026/Q3 | +440,884 | 4.7% |
| Western Standard, LLC | Hedge Fund | 2026/Q3 | +387,188 | 0.9% |
| AQR Capital Management | Hedge Fund | 2026/Q3 | +335,145 | 1.4% |
| Armistice Capital LLC | Hedge Fund | 2026/Q3 | +329,000 | 5.2% |
| J.P. Morgan Asset Management, Inc. | Mutual Fund | 2026/Q3 | +193,751 | 0.5% |
| Systematic Financial Management LP | Mutual Fund | 2026/Q3 | +186,513 | 6.3% |
| Millennium Management LLC | Hedge Fund | 2026/Q3 | +138,448 | 1.9% |
| BlackRock | Mutual Fund | 2026/Q3 | +117,328 | 9.0% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 29 Jul 2026 | Warren Nighan | Senior Vice President of Regulatory Affairs, Quality & Global Supply Chain | Open Market Disposition | -23,370 | $14.72 | 64,745 |
| 21 Jul 2026 | Warren Nighan | Senior Vice President of Regulatory Affairs, Quality & Global Supply Chain | Derivative Exercise and Sale | -1,671 | $13.82 | 88,115 |
| 21 Jul 2026 | Warren Nighan | Senior Vice President of Regulatory Affairs, Quality & Global Supply Chain | Derivative Exercise and Retained | +4,023 | – | 88,115 |
| 21 Jul 2026 | James Clemmer | Chief Executive Officer | Derivative Exercise and Sale | -26,728 | $13.82 | 629,899 |
| 21 Jul 2026 | James Clemmer | Chief Executive Officer | Derivative Exercise and Retained | +25,630 | – | 629,899 |
| 21 Jul 2026 | Stephen Trowbridge | Chief Financial Officer | Derivative Exercise and Sale | -8,319 | $13.82 | 160,642 |
| 21 Jul 2026 | Stephen Trowbridge | Chief Financial Officer | Derivative Exercise and Retained | +7,977 | – | 160,642 |
| 21 Jul 2026 | Laura Piccinini | Senior VP and GM of Cardiovascular & International | Derivative Exercise and Sale | -4,506 | $13.82 | 81,929 |
| 21 Jul 2026 | Laura Piccinini | Senior VP and GM of Cardiovascular & International | Derivative Exercise and Retained | +3,541 | – | 81,929 |
| 21 Jul 2026 | Chad Campbell | Senior VP and GM of Oncology & Interventional Devices | Derivative Exercise and Sale | -2,330 | $13.82 | 63,873 |
| 21 Jul 2026 | Chad Campbell | Senior VP and GM of Oncology & Interventional Devices | Derivative Exercise and Retained | +4,136 | – | 63,873 |
| 19 Jul 2026 | Warren Nighan | Senior Vice President of Regulatory Affairs, Quality & Global Supply Chain | Sale to Issuer | -3,777 | $14.14 | 66,126 |
| 19 Jul 2026 | James Clemmer | Chief Executive Officer | Sale to Issuer | -45,711 | $14.14 | 604,269 |
| 19 Jul 2026 | Stephen Trowbridge | Chief Financial Officer | Sale to Issuer | -12,067 | $14.14 | 152,665 |
| 19 Jul 2026 | Laura Piccinini | Senior VP and GM of Cardiovascular & International | Sale to Issuer | -8,228 | $14.14 | 58,528 |
| 19 Jul 2026 | Chad Campbell | Senior VP and GM of Oncology & Interventional Devices | Sale to Issuer | -3,838 | $14.14 | 59,737 |
| 15 Jul 2026 | Lawrence Weiss | Chief Legal Officer | Sale to Issuer | -2,267 | $14.14 | 28,632 |
| 14 Jul 2026 | Jan Reed | Independent Director | Other Acquisition | +11,887 | – | 116,921 |
| 14 Jul 2026 | Wesley Johnson | Independent Director | Other Acquisition | +11,887 | – | 155,425 |
| 14 Jul 2026 | Howard Donnelly | Independent Non-Executive Chairperson | Other Acquisition | +11,887 | – | 178,938 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 1,916,701 | 4.6% | 1.5 |
| 30 Sep 2026 | 1,294,595 | 3.1% | 2.2 |
| 15 Sep 2026 | 1,343,344 | 3.3% | 3.5 |
| 31 Aug 2026 | 1,363,549 | 3.3% | 5.4 |
| 14 Aug 2026 | 1,353,475 | 3.3% | 2.5 |
| 31 Jul 2026 | 1,221,837 | 3.0% | 2.5 |
暂无评论——快来第一个聊聊 ANGO。